| Structure | Chemical Name | CAS | MF |
|
Imidazo[1,2-a]pyrazine, 3-nitroso- (9CI)
|
572910-75-9
|
C6H4N4O
|
|
Imidazo[1,2-a]pyrazine, 5-methoxy- (9CI)
|
572910-76-0
|
C7H7N3O
|
|
Imidazo[1,5-a]pyrimidin-4(1H)-one, 2-methyl- (9CI)
|
572910-80-6
|
C7H7N3O
|
|
1H-Azepine-2,4(3H,5H)-dione,dihydro-1-methyl-(9CI)
|
572911-11-6
|
C7H11NO2
|
|
1H-Azepine-2,4(3H,5H)-dione,dihydro-1-(1-methylethyl)-(9CI)
|
572911-13-8
|
C9H15NO2
|
|
Ethyl 6-[(2-Cyanoethoxy)(4,4-diphenylcyclohexyloxy)phosphoryloxy]hexanoate
|
572913-59-8
|
C29H38NO6P
|
|
3,6-Benzofurandiol (9CI)
|
572916-04-2
|
C8H6O3
|
|
4-Pyrimidinecarboxylicacid,5-ethoxy-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-(9CI)
|
572917-55-6
|
C8H10N2O5
|
|
2-Imidazolidinone,1-(3-methyl-5-isoxazolyl)-(9CI)
|
572922-65-7
|
C7H9N3O2
|
|
2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1-(1,1-dimethylethyl)-3-methyl- (9CI)
|
572922-76-0
|
C9H16N4O2
|
|
2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-3-methyl-1-(1-methylpropyl)- (9CI)
|
572922-77-1
|
C9H16N4O2
|
|
(S)-4-Methyl-3-(4-trifluoromethylphenyl)oxazolidin-2-one
|
572922-96-4
|
C11H10F3NO2
|
|
(S)-4-Ethyl-3-phenyloxazolidin-2-one
|
572922-97-5
|
C11H13NO2
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzaldehyde
|
572922-98-6
|
C12H13NO3
|
|
(S)-4-(2-Oxo-4-phenyloxazolidin-3-yl)benzaldehyde
|
572922-99-7
|
C16H13NO3
|
|
(S)-4-(4-Isopropyl-2-oxooxazolidin-3-yl)benzaldehyde
|
572923-00-3
|
C13H15NO3
|
|
(S)-4-Ethyl-3-(3-methoxyphenyl)oxazolidin-2-one
|
572923-01-4
|
C12H15NO3
|
|
(S)-3-(3-Methoxyphenyl)-4-phenyloxazolidin-2-one
|
572923-03-6
|
C16H15NO3
|
|
(S)-4-Phenyl-3-p-tolyloxazolidin-2-one
|
572923-05-8
|
C16H15NO2
|
|
(S)-4-Ethyl-3-p-tolyloxazolidin-2-one
|
572923-06-9
|
C12H15NO2
|
|
(S)-4-Ethyl-3-(4-methoxyphenyl)oxazolidin-2-one
|
572923-07-0
|
C12H15NO3
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzonitrile
|
572923-10-5
|
C12H12N2O2
|
|
(S)-4-Ethyl-3-(4-nitrophenyl)oxazolidin-2-one
|
572923-12-7
|
C11H12N2O4
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzoic acid methyl ester
|
572923-13-8
|
C13H15NO4
|
|
(S)-3-(3-Acetylphenyl)-4-ethyloxazolidin-2-one
|
572923-14-9
|
C13H15NO3
|
|
(S)-2-(4-Ethyl-2-oxooxazolidin-3-yl)benzonitrile
|
572923-15-0
|
C12H12N2O2
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)-N-propylbenzamide
|
572923-16-1
|
C15H20N2O3
|
|
(S)-4-(2-Oxo-4-phenyloxazolidin-3-yl)-N-propylbenzamide
|
572923-17-2
|
C19H20N2O3
|
|
(S)-3-(4-Acetylphenyl)-4-ethyloxazolidin-2-one
|
572923-18-3
|
C13H15NO3
|
|
(S)-3-(4-Acetylphenyl)-4-isopropyloxazolidin-2-one
|
572923-19-4
|
C14H17NO3
|
|
(S)-3-(4-Acetylphenyl)-4-phenyloxazolidin-2-one
|
572923-21-8
|
C17H15NO3
|
|
(S)-2-(4-Trifluoromethylphenylamino)propan-1-ol
|
572923-22-9
|
C10H12F3NO
|
|
(S)-4-(1-Hydroxymethyl-propylamino)benzaldehyde
|
572923-24-1
|
C11H15NO2
|
|
(S)-4-(2-Hydroxy-1-phenyl-ethylamino)benzaldehyde
|
572923-25-2
|
C15H15NO2
|
|
(S)-2-Phenyl-2-p-tolylamino-ethanol
|
572923-26-3
|
C15H17NO
|
|
(S)-2-p-Tolylamino-butan-1-ol
|
572923-27-4
|
C11H17NO
|
|
(S)-2-(4-Methoxyphenylamino)butan-1-ol
|
572923-28-5
|
C11H17NO2
|
|
(S)-4-(1-Hydroxymethyl-propylamino)benzonitrile
|
572923-29-6
|
C11H14N2O
|
|
(S)-2-(4-Nitrophenylamino)butan-1-ol
|
572923-31-0
|
C10H14N2O3
|
|
(S)-1-[4-(1-Hydroxymethylpropylamino)phenyl]ethanone
|
572923-32-1
|
C12H17NO2
|
|
(S)-2-Cyclopentyloxycarbonylamino-3,3-dimethyl-butyric acid
|
572924-00-6
|
C12H21NO4
|
|
3-Deoxy-11,13-dihydroisosecotanapartholide
|
572924-43-7
|
C15H20O4
|
|
42-(Dimethylphosphinate)rapamycin
|
572924-54-0
|
C53H84NO14P
|
|
GenBank CD800910
|
573181-44-9
|
C7H3BrClN
|
|
ANTI-THOMSEN-FRIEDENREICH CARCINOMA ANTIGEN PEPTIDE P30-1
|
573664-50-3
|
C94H130N26O19
|
|
BOMBINAKININ-GAP
|
573671-91-7
|
C145H219N39O39S3
|
|
2-Pyridinecarboxylic acid, 4-[4-[[[[4-chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]phenoxy]-, Methyl ester
|
573673-43-5
|
C21H15ClF3N3O4
|
|
2-[(5Z)-5-(4-fluorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanedioic acid
|
573673-95-7
|
C14H10FNO5S2
|
|
1-Naphthalenecarboxylic acid, 4-hydroxyphenyl ester
|
573674-19-8
|
C17H12O3
|
|
5-Bromo-3-nitropyridine-2-carbonitrile
|
573675-25-9
|
C6H2BrN3O2
|
|
3-Amino-5-bromo-pyridine-2-carbonitrile
|
573675-27-1
|
C6H4BrN3
|
|
7-Bromopyrido[3,2-d]pyrimidin-4(3H)-one
|
573675-29-3
|
C7H4BrN3O
|
|
7-bromo-4-chloropyrido[3,2-d]pyrimidine
|
573675-31-7
|
C7H3BrClN3
|
|
4-broMo-2-(dibroMoMethyl)benzonitrile
|
573675-37-3
|
C8H4Br3N
|
|
5-bromo-3-hydroxyisoindolin-1-one
|
573675-39-5
|
C8H6BrNO2
|
|
7-Bromo-4-chloroquinazoline
|
573675-55-5
|
C8H4BrClN2
|
|
3-Fluoro-2-(tributylstannyl)pyridine
|
573675-60-2
|
C17H30FNSn
|
|
4-Chloro-7-[3-(trifluoromethyl)pyridin-2-yl]quinazoline
|
573675-83-9
|
C14H7ClF3N3
|
|
2-Methyl-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-ol
|
573675-91-9
|
C15H10F3N3O
|
|
Benzoic acid, 2-amino-4-borono-, 1-ethyl ester (9CI)
|
573675-99-7
|
C9H12BNO4
|
|
2-(4-Methyl-3-nitrophenyl)-3-(trifluoromethyl)pyridine
|
573676-05-8
|
C13H9F3N2O2
|
|
2-nitro-4-(3-trifluoroMethylpyridin-2-yl)benzoic acid
|
573676-07-0
|
C13H7F3N2O4
|
|
2-aMino-4-(3-trifluoroMethylpyridin-2-yl)benzoic acid
|
573676-09-2
|
C13H9F3N2O2
|
|
Pyridine,2-[(1-methylethyl)thio]-5-nitro-(9CI)
|
573676-13-8
|
C8H10N2O2S
|
|
3-Pyridinamine,6-[(1-methylethyl)sulfonyl]-(9CI)
|
573676-17-2
|
C8H12N2O2S
|
|
N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine
|
573678-04-3
|
C21H12F6N4
|
|
BUTTPARK 144\07-81
|
573681-17-1
|
C9H6BrClN2O
|
|
7-Bromo-4-chloro-2-chloromethyl-quinazoline
|
573681-19-3
|
C9H5BrCl2N2
|
|
2(1H)-Quinolinethione, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-
|
573691-04-0
|
C23H27Cl2N3OS
|
|
Aripiprazole N1-Oxide
|
573691-09-5
|
C23H27Cl2N3O3
|
|
Aripiprazole N4-Oxide
|
573691-11-9
|
C23H27Cl2N3O3
|
|
Aripiprazole N,N-Dioxide
|
573691-13-1
|
C23H27Cl2N3O4
|
|
5-Quinoxalinecarbonitrile,1,2,3,4-tetrahydro-6-methyl-2-oxo-(9CI)
|
573692-38-3
|
C10H9N3O
|
|
Methyl 6-amino-3-bromo-2-methylbenzoate, 98%
|
573692-58-7
|
C9H10BrNO2
|
|
{7-[(2-chlorobenzyl)oxy]-4-methyl-2-oxo-2H-chromen-3-yl}acetic acid
|
573693-51-3
|
C19H15ClO5
|
|
ethyl 3-[6-chloro-7-(2-chloroprop-2-enoxy)-4-methyl-2-oxochromen-3-yl]propanoate
|
573694-21-0
|
C18H18Cl2O5
|
|
3-(Anilinomethyl)-7-methylquinolin-2(1H)-one
|
573696-33-0
|
C17H16N2O
|
|
6-chloro-8-[(dimethylamino)methyl]-4-ethyl-7-hydroxy-2H-chromen-2-one
|
573696-81-8
|
C14H16ClNO3
|
|
3-Pyridinecarbonitrile,2-amino-6-methyl-5-propyl-4-(1H-pyrrol-2-yl)-(9CI)
|
573697-30-0
|
C14H16N4
|
|
2-{2-[4-(2-methoxyphenyl)-1-piperazinyl]-2-oxoethyl}-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
|
573697-71-9
|
C20H21N3O5S
|
|
(3Z)-3-[2-(3,4-dimethoxyphenyl)-6-oxo[1,3]thiazolo[3,2-b][1,2,4]triazol-5(6H)-ylidene]-1-ethyl-1,3-dihydro-2H-indol-2-one
|
573697-94-6
|
C22H18N4O4S
|
|
2-[(4-bromophenoxy)methyl]-5-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3-oxazole-4-carbonitrile
|
573698-41-6
|
C22H21BrN4O3
|
|
Succinimide, N-1,3-butadienyl-, trans- (7CI)
|
573700-49-9
|
C8H9NO2
|
|
methyl 2-amino-2-(2-fluorophenyl)acetate
|
573701-88-9
|
C9H10FNO2
|
|
3-Oxazolidinecarboxylic acid, 5-oxo-2,4-diphenyl-, phenylmethyl ester, (2S,4R)-
|
573703-18-1
|
C23H19NO4
|
|
Cyclopentaneethanol, 3-hydroxy-2-(2Z)-2-pentenyl-, (1R,2R)-rel- (9CI)
|
573703-57-8
|
C12H22O2
|
|
Melphalan Impurity I
|
573704-40-2
|
C14H21ClN2O3
|
|
Melphalan Mono-chloroethyl Impurity
|
573704-41-3
|
C11H15ClN2O2
|
|
N-(2-chloro-3,5-dimethoxyphenyl)acetamide
|
573704-48-0
|
C10H12ClNO3
|
|
(S)-1-Cbz-3-pyrrolidinecarboxaMide
|
573704-57-1
|
C13H16N2O3
|
|
(3S)-3-Pyrrolidinecarboxamide
|
573704-64-0
|
C5H10N2O
|
|
1,3-Cyclopentanediamine,(1R,3R)-rel-(9CI)
|
573704-66-2
|
C5H12N2
|
|
N-(2-furylmethyl)-2-imino-1-(4-methylbenzyl)-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2,3-d]pyrimidine-3-carboxamide
|
573705-70-1
|
C25H21N5O3
|
|
2-[(dimethylammonio)methyl]-4-methyl-6-oxo-6H-benzo[c]chromen-3-olate
|
573707-14-9
|
C17H17NO3
|
|
4-[(Z)-2-(1H-benzimidazol-2-yl)-1-hydroxyethenyl]-6-chlorobenzene-1,3-diol
|
573707-73-0
|
C15H11ClN2O3
|
|
2-imino-1-[2-(4-methoxyphenyl)ethyl]-N-(4-methylbenzyl)-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide
|
573707-94-5
|
C29H27N5O3
|
|
N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-(4-methoxybenzyl)-2-oxo-2H-chromene-3-carboxamide
|
573707-95-6
|
C22H21NO6S
|
|
6-(azepan-1-yl)-N~2~-(3,4-dimethylphenyl)-5-nitropyrimidine-2,4-diamine
|
573709-35-0
|
C18H24N6O2
|
|
3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)aniline
|
573711-38-3
|
C10H10BrN3
|
|
2H-1,2,3-Triazole-4-carboxylic acid
|
573714-78-0
|
C3H3N3O2
|